Supporting Men's Health Research

In Movember, we highlight those patients who support men's health research either by participating in research or becoming involved with research projects as advisors with lived experience.   

The Irish Prostate Cancer Outcomes Research (IPCOR) project established a prospective national prostate cancer registry, which collected clinical data on 6816 newly diagnosed prostate cancer patients in 16 hospitals across Ireland from 2016 to 2020.

The registry also collected patient reported data from 873 men. The project was funded by Movember in partnership with the Irish Cancer Society. The IPCOR registry is housed in UCD and is currently being utilised in research aimed at improving prostate cancer care in Ireland. Mr David Galvin, consultant urologist in St Vincent's & the Mater Misericordiae University Hospitals, is the principal investigator on the IPCOR project.

IPCOR is entering an exciting new stage and is establishing a new prostate cancer clinical quality registry and biobank funded by Movember. The registry will recruit men being investigated for prostate cancer, collect clinical and patient reported data over time and set up a biobank. The programme aims to assess quality of care, men’s wellbeing, and their quality of life; to conduct clinically informed translational research; and to enhance clinical trial participation through utilisation of the registry.

IPCOR has set up a lived experience advisory panel (LEAP) to work with UCD researchers to provide their insights and ideas during the establishment and conduct of the research programme. The LEAP panel has 11 men who were diagnosed with and treated for prostate cancer. LEAP ensures that IPCOR’s research focuses on issues that matter most to men at each stage of their prostate cancer journey.

"It's great to be part of the LEAP group and to have the opportunity to work with the IPCOR team on this crucial research project, and the team is very committed to ensuring that the research focuses on patient needs based on our lived experience as men who have been through diagnosis and treatment of prostate cancer. Our mission is to make things better for the next generation of men diagnosed with prostate cancer." Martin Sweeney, Chair of LEAP.

Each year, the scientists in UCD Conway Institute support the Movember campaign to raise awareness and fundraise for a great cause. Prof. William (Bill) Watson lead this initiative with colleagues. In November 2022 to date, they have raised €1625 through Movember pledges and the annual bake sale. Thank you for supporting men's health.

Pictured l-r: PhD student, Alfie O'Sullivan, Dr Eoin Cummins, Dr José Augusto Gonzales Castillo, Dr David Phelan. Prof. William (Bill) Watson.